1046 completed, 199 recruiting, 103 withdrawn, 93 terminated. 912 Not applicable, 233 Phase 2, 135 Phase 1, 116 Phase 4, 73 Phase 3.
Follow University of California, Los Angeles: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis Cannabidiol (CBD), Placebo - Schizophrenia Spectrum Disorders, Cannabis Use | Phase 2 | Withdrawn | University of Maryland, Baltimore | 2050-01-01 | 2021-04-19 | |
| Safety Profile of Psilocybin for Cocaine Use Disorder Psilocybin - Cocaine Use Disorder | Early Phase 1 | Suspended | University of California, Los Angeles | 10 | 2029-02-01 | 2026-04-07 |
| Mapping Patient Decision-making in Thyroid Cancer Decision navigation tool - Thyroid Cancer | Not applicable | Not yet recruiting | University of California, Los Angeles | 50 | 2028-04-01 | 2026-07-24 |
| Sodium Lactate in Severe TBI Sodium Lactate, placebo - Traumatic Brain Injury | Phase 2 | Not yet recruiting | University of California, Los Angeles | 264 | 2028-01-10 | 2026-01-16 |
| Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso PfSPZ-LARC2 Vaccine, PfSPZ Challenge, Normal Saline - Malaria (Plasmodium Falciparum) | Phase 1 | Not yet recruiting | Sanaria Inc. | 45 | 2027-03-01 | 2026-07-31 |
| rTMS for Aneroxia Nervosa in Youth Transcranial Magnetic Treatment - Anorexia Nervosa | Not applicable | Not yet recruiting | University of California, Los Angeles | 45 | 2027-01-30 | 2026-04-24 |
| Group PACBT for Depression Psilocybin (drug), Group Cognitive Behavioral Therapy - Depression - Major Depressive Disorder, Psilocybin | Phase 2 | Not yet recruiting | University of California, Los Angeles | 30 | 2027-01-01 | 2026-05-04 |
| Wearable Sensor for Early Detection and Monitoring of Cognitive Decline Mild Cognitive Impairment (MCI), Older Adults With Cognitive Decline | Not yet recruiting | BioSensics | 100 | 2026-12-15 | 2026-09-02 | |
| Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen - Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI) | Phase 4 | Not yet recruiting | University of California, Los Angeles | 120 | 2026-11-01 | 2026-09-15 |
| Knotless Versus Conventional Sutures for Wound Closure in Cerebral Palsy Multilevel Surgery Knotless barbed suture, Conventional suture - Cerebral Palsy | Not applicable | Not yet recruiting | University of California, Los Angeles | 50 | 2026-11-01 | 2026-10-19 |
| FIQS Dissemination and Implementation Text-Only Enrollment Strategy, Text Plus In-Person Enrollment Strategy, Anonymous Safety Reporting with Impact Website - Inpatient Experience Survey Administration, Inpatient Experience Survey Response | Not applicable | Not yet recruiting | University of California, San Francisco | 21800 | 2026-10-19 | 2026-10-13 |
| UCLA Magnesium Formulation Athlete Study Magnesium glycinate, Magnesium L-threonate, Placebo - Athletic Performance, Recovery | Not applicable | Recruiting | University of California, Los Angeles | 150 | 2026-10-05 | 2026-10-15 |
| The ACT-PrEP Study POC STI testing, CBC, and partner self-testing to improve PrEP uptake and persistence among pregnant and postpartum women., Standard of Care - HIV, PrEP | Not applicable | Not yet recruiting | University of California, Los Angeles | 120 | 2026-10-02 | 2026-10-09 |
| INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study INSPIRE (INtegrating Systematic PatIent-Reported Evaluations), Capture of patient-reported outcomes, Enhanced Clinician Awareness - Breast Cancer, Corpus Uteri Cancer | Not applicable | Recruiting | University of Alabama at Birmingham | 2748 | 2026-10-02 | 2026-10-07 |
| Pre-emptive RTO for An Early Detected Gastric Varices in CT/MR Angiogram Trial Non-selective beta blockers, Retrograde transvenous obliteration - Gastric Varices | Not applicable | Not yet recruiting | University of California, Los Angeles | 68 | 2026-10-01 | 2026-07-02 |
| THCV Treatment for Smokers Δ9-Tetrahydrocannabivarin (oral gummy), Matched Placebo (oral gummy) - Tobacco Use Disorder, Smoking Cessation | Phase 2 | Not yet recruiting | University of California, Los Angeles | 32 | 2026-10-01 | 2026-08-04 |
| People & Place: Impacts on Substance Use and HIV Outcomes in Los Angeles Adapted LINK LA Peer Navigator - HIV | Not applicable | Not yet recruiting | University of California, Los Angeles | 250 | 2026-10-01 | 2026-07-27 |
| Refugee Mental Health and Wellness Pilot Study Wellbeing Program - Social Isolation | Not applicable | Withdrawn | University of California, Los Angeles | 2026-10-01 | 2026-10-21 | |
| Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis Suicide Prevention Intervention, Standard Care (in control arm) - Clinical High Risk for Psychosis (CHR), Suicidal Ideation | Not applicable | Recruiting | University of California, San Diego | 108 | 2026-10-01 | 2026-10-22 |
| C-Carbs: A CGM-guided Approach to Teaching Carb Awareness C-Carbs Program - Type 1 Diabetes | Not applicable | Recruiting | University of California, Los Angeles | 40 | 2026-09-30 | 2026-09-08 |
Showing 20 of 1691. Sign in to see all of them.
Depression (100) · Anxiety Disorders (61) · Substance-Related Disorders (61) · HIV Infections (46) · Acquired Immunodeficiency Syndrome (39) · Depressive Disorder, Major (39) · Obesity (39) · Schizophrenia (39) · Stroke (37) · Opioid-Related Disorders (32) · Cognitive Dysfunction (31) · Inflammation (27) · Psychotic Disorders (26) · Autistic Disorder (25) · Autism Spectrum Disorder (24)
Cognitive Behavioral Therapy (27) · Standard of Care (20) · Sugars (17) · Therapeutics (14) · Transcranial Magnetic Stimulation (12) · Exercise (11) · Buprenorphine (10) · Sodium Chloride (10) · Activator Appliances (7) · Behavior Therapy (7) · Bupropion (7) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (7) · Endotoxins (7) · Methods (7) · Mindfulness (7)
United States (1462) · Canada (34) · South Africa (22) · United Kingdom (16) · China (15) · Italy (10) · Malawi (10) · India (9) · Japan (8) · Peru (8) · Spain (8) · Vietnam (8) · Australia (6) · Brazil (6) · France (6)
Zhaoping Li, MD, PhD (22) · Walter Ling, M.D. (17) · Lara Ray, PhD (9) · David Heber, MD, PhD (7) · Zhaoping Li (7) · Helen Lavretsky, M.D. (6) · Ian A Cook, MD (6) · Michelle G Craske, PhD (6) · Peter Szilagyi, MD (6) · Ziva Cooper, PhD (6) · Adam Schickedanz, MD (5) · Adeline Nyamathi, PhD (5) · Jesse L Clark, MD, MSc (5) · Li Li, PhD (5) · Sachin Wani, MD (5)
PMID 36094829, PMID 37310308, PMID 38045238, PMID 38167321, PMID 21876461, PMID 22224835, PMID 24839882, PMID 26107752, PMID 26954267, PMID 27567470, PMID 28433500, PMID 28901969, PMID 29070502, PMID 29191814, PMID 30600690, PMID 30878250, PMID 30926571, PMID 31234842, PMID 32025629, PMID 32446470, PMID 33006765, PMID 33705167, PMID 33846054, PMID 33974366, PMID 34085132, PMID 34287756, PMID 34460285, PMID 34770374, PMID 34995162, PMID 35097151, PMID 35138678, PMID 35917136, PMID 36067410, PMID 36828925, PMID 36947792, PMID 36951854, PMID 37070270, PMID 37795521, PMID 38616571, PMID 38719439, PMID 38803132, PMID 39399024, PMID 39780302, PMID 40018627, PMID 40342086, PMID 40779812, PMID 40833692, PMID 40928164, PMID 41916615, PMID 10555885
P50DA018185 (7), R01AI135029 (7), UL1TR000124 (7), R01CA202261 (6), P50DA009260 (4), U10DA013045 (4), U19MH108206 (4), R01CA198887 (3), R18DA006082 (3), UL1TR001881 (3), UM1CA121947 (3), 2025 (2), D43TW012186 (2), K23NS119568 (2), K24DK002650 (2)